90 results
Page 3 of 5
S-3ASR
biy98nx1fxp36pohehpv
10 Aug 20
Automatic shelf registration
5:01pm
424B5
1jlp3vo4
2 Jun 20
Prospectus supplement for primary offering
5:05pm
424B5
xsdmg
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
zui90iytn wxn
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
phot9ye8f svzplt
22 Jan 20
Prospectus supplement for primary offering
5:31pm
424B5
19alx1g86 0iod
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
66tsnznzv
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-99.1
lzszk
1 Aug 19
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
7:23am
8-K
EX-99.1
ak3b1o9z0r1jv0p8
18 Jul 19
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses
8:11am
8-K
EX-10.4
cx1k0f6dbzd3s ab8
27 Jun 19
Departure of Directors or Certain Officers
8:08am